Examen
NURS 5334 DIABETES MELLITUS CASE STUDY 3
- Grado
- Institución
NURS 5334 DIABETES MELLITUS CASE STUDY 3/NURS 5334 DIABETES MELLITUS CASE STUDY 3/NURS 5334 DIABETES MELLITUS CASE STUDY 3
[Mostrar más]Vista previa 2 fuera de 10 páginas
Vista previa 2 fuera de 10 páginas
Añadir al carrito
Añadir al carrito
Vendedor
Seguir
Ultimatenurse
Comentarios recibidos
Vista previa del contenido
NURS 5334 DIABETES MELLITUS CASE STUDY 3NURS 5334 DIABETES MELLITUS CASE STUDY 3
Diabetic Case Study
University of Texas Arlington College of Nursing and Health Innovation
Nursing 5334 Advanced Pharmacology for NPs
Lynda Jarrell, DNP, APRN, FNP-BC
, NURS 5334 DIABETES MELLITUS CASE STUDY 3
Assessment:
Patient is a 55 years old female with the symptoms of urinary frequency, urinary
urgency, and burning on urination with the history of urinary tract infection. Patient’s vital
signs are blood pressure 150/90 mm Hg, pulse 72, Ht 5 feet 5 inches, weight 180 lbs.
Furthermore, urinalysis confirms urinary tract infection and shows protein and high
glucose level in the urine. Patient has a random plasma glucose level of 220 mg/dL.
Patient has a family history of type 2 diabetes. Marion’s laboratory findings are as
follows:
• Fasting plasma glucose 180 mg/dL
Total cholesterol 250
• Triglycerides 350 mg/dL
• High-density lipoprotein cholesterol 35 mg/dL
• Low-density lipoprotein cholesterol 164 mg/dL
• HbA1c 7.4%
• Serum creatinine 1.2
• Glomerular filtration rate >60
• Thyroid function studies within normal limits
Based on the collected labs with the presenting symptoms, the assessment of the
patient are diabetes type II, hypertension, hyperlipidemia and obesity.
Plan:
The patient’s treatment plan will include an antihypertensive medication such as
Angiotensin coverting enzyme (ACE) inhibitor or an Angiotensin II receptor blocker
(ARB) to reduce blood pressure along with a statin to address the hyperlipidemia. In
addition, the patient will also require a glucose lowering agent to maintain glycemic
control. Patient education will be provided regarding to life style changes such as weight
loss, diet, diabetes self-management and physical activity. Cardiac risk calculation per
http://www.cvriskcalculator.com is 13.2%
Pharmacologic:
1. Metformin 500 mg by mouth twice a day for diabetes type II
2. Lovastatin 20 mg by mouth daily for hyperlipidemia
3. Lisinopril 10 mg by mouth daily for hypertension
Los beneficios de comprar resúmenes en Stuvia estan en línea:
Garantiza la calidad de los comentarios
Compradores de Stuvia evaluaron más de 700.000 resúmenes. Así estas seguro que compras los mejores documentos!
Compra fácil y rápido
Puedes pagar rápidamente y en una vez con iDeal, tarjeta de crédito o con tu crédito de Stuvia. Sin tener que hacerte miembro.
Enfócate en lo más importante
Tus compañeros escriben los resúmenes. Por eso tienes la seguridad que tienes un resumen actual y confiable. Así llegas a la conclusión rapidamente!
Preguntas frecuentes
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
100% de satisfacción garantizada: ¿Cómo funciona?
Nuestra garantía de satisfacción le asegura que siempre encontrará un documento de estudio a tu medida. Tu rellenas un formulario y nuestro equipo de atención al cliente se encarga del resto.
Who am I buying this summary from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller Ultimatenurse. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy this summary for $14.99. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
45,681 summaries were sold in the last 30 days
Founded in 2010, the go-to place to buy summaries for 14 years now